Literature DB >> 1902853

Regulation of IgM and IgD expression in human B-lineage cells.

W G Kerr1, L M Hendershot, P D Burrows.   

Abstract

IgD is thought to function primarily as an Ag receptor that is expressed, together with IgM, only on mature B lymphocytes. This differentiation stage-specific expression of IgD has been well characterized in mice, where delta mRNA is detected only in mature IgM/IgD B cells. Humans, in contrast to mice, have significant levels of serum IgD, suggesting that the regulation of this isotype might differ between the two species. Therefore, we examined the regulation of both IgM and IgD expression in cell lines encompassing the spectrum of human B lineage development. Surprisingly, two species of delta mRNA could be found at all differentiation stages -from mu+ pre-B cell to IgM-secreting plasmablast. These mRNA are translated to yield the membrane and secretory forms of delta. The membrane delta-chain: secretory delta-chain ratio did not necessarily reflect the membrane mu-chain:secretory mu-chain ratio in the same cell line, implying that different mechanisms are involved in the selection of membrane vs secretory mu- and delta-chains. The delta-chains synthesized in pre-B cells were degraded, but in more mature cell types IgD could be stably expressed and secreted. Exceptions to this panlineage synthesis of delta-chains were, however, observed in two of the B cell lymphomas, where delta expression was prevented by transcriptional and posttranscriptional mechanisms. The presence of delta-chain in pre-B cells and the secretion of IgD by more mature cells suggest that IgD may have immunoregulatory roles throughout B cell differentiation. These studies also indicated that the bias toward secretory mu-chain production that occurs in human IgM secreting cells results from posttranscriptional regulation. In addition, we have identified a B cell line that synthesizes both normal-sized mu-chains and those with smaller apparent m.w. translation products of truncated mu mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902853

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Fugu immunoglobulin D: a highly unusual gene with unprecedented duplications in its constant region.

Authors:  Nil Ratan Saha; Hiroaki Suetake; Kiyoshi Kikuchi; Yuzuru Suzuki
Journal:  Immunogenetics       Date:  2004-08-26       Impact factor: 2.846

Review 2.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Authors:  Floriane Fusil; Sara Calattini; Fouzia Amirache; Jimmy Mancip; Caroline Costa; Justin B Robbins; Florian Douam; Dimitri Lavillette; Mansun Law; Thierry Defrance; Els Verhoeyen; François-Loïc Cosset
Journal:  Mol Ther       Date:  2015-08-18       Impact factor: 11.454

4.  The truth on IgD in the ploy of immune surveillance and inflammation.

Authors:  Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 5.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

Review 6.  The function and regulation of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Curr Opin Immunol       Date:  2011-02-24       Impact factor: 7.486

7.  CXCR4 signaling and function require the expression of the IgD-class B-cell antigen receptor.

Authors:  Martin Becker; Elias Hobeika; Hassan Jumaa; Michael Reth; Palash C Maity
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

8.  FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA.

Authors:  Teresa Santiago; Sergei V Kulemzin; Evdokia S Reshetnikova; Nikolai A Chikaev; Olga Y Volkova; Ludmila V Mechetina; Meina Zhao; Randall S Davis; Alexander V Taranin; Alexander M Najakshin; Linda M Hendershot; Peter D Burrows
Journal:  Int Immunol       Date:  2010-12-13       Impact factor: 4.823

9.  Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.

Authors:  K A Taylor; S Wetzel; D S Lyles; B A Pollok
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains.

Authors:  W G Kerr; M Heller; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.